• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial

byJayden BerdugoandSimon Pan
November 14, 2025
in Chronic Disease, Emergency, Neurology, Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this randomized clinical trial, combination therapy with diphenhydramine and sodium bicarbonate was associated with decreased vertigo compared to therapy with diphenhydramine alone. 

Evidence Rating Level: 1 (Excellent) 

Vertigo is characterized as a spinning sensation that is usually accompanied by nausea and vomiting, leading many patients to seek emergency care. In Taiwan, about 3% of adults experience vertigo, with frequent recurrences. In the emergency department (ED), the priority is to rule out serious central causes and alleviate symptoms quickly. Previous research has shown support for antihistamines; however, they often cause fatigue and increase fall risk, particularly in older adults. Another potential treatment option could be sodium bicarbonate, which is typically used to treat acidosis, but has shown potential to ease vertigo symptoms by improving inner ear blood flow and calming vestibular nerves. As such, this double-blinded randomized clinical trial compared sodium bicarbonate, antihistamines, and their combination for treating acute peripheral vertigo in the ED. Participants were randomized in a 1:1:1 ratio to receive either intravenous diphenhydramine (group A), sodium bicarbonate (group B), or both agents (group C). A total of 222 participants (mean [SD] age, 57.9 [17.6] years) were included in the study. Vertigo scores decreased by a mean (SD) of -4.4 (2.7), -5.1 (2.2), and -5.6 (2.1) in groups A, B, and C, respectively, with group C having significantly greater improvement than group A (P=.01). Fewer participants in group C required rescue therapy compared to group A (17.8% [13 of 73] vs 46.7% [35 of 75]; P<.001). Moderate lethargy was more frequently reported in the diphenhydramine groups (group A, 38.7% [29 of 75]; group C, 30.1% [22 of 73]) than in the sodium bicarbonate group (8.1% [6 of 74]; P<.001). Overall, in patients with acute peripheral, a combination of sodium bicarbonate and diphenhydramine provided greater symptom relief than diphenhydramine alone, and sodium bicarbonate alone was similarly effective while causing less lethargy. 

Click here to read this study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo

Tags: diphenhydramineemergency medicineneurologyperipheral vertigosodium bicarbonate
Previous Post

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

RelatedReports

2 Minute Medicine Rewind August 19, 2019
Chronic Disease

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

November 13, 2025
Chronic Disease

Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study

November 12, 2025
Abusive head trauma results in fewer productive life-years
Emergency

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo

November 10, 2025
Weekly Rewinds

2 Minute Medicine Rewind November 10th, 2025

November 10, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial
  • Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study
  • Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.